• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Brickell Biotech

edit

Brickell Biotech, Inc., a Delaware corporation, is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.

Recent Milestones

edit

• 
  Brickell Biotech received $7M in Series B funding. (2/26/13)
  Posted 2/26/13 at 7:43pm via yahoo.com

Videos

Screenshots

edit

Above: Brickell Biotech
Uploaded: 2/27/13

Sources

1. Brickell Biotech Announces $7M Series B Financing to Fund Development of Novel Dermatology Treatments (news.yahoo.com) [edit]